髓细胞触发受体1(TREM1)多克隆抗体
Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
CD354; Triggering Receptor Expressed On Monocytes-1
- 编号PAA213Mu01
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPA213Mu01-髓细胞触发受体1(TREM1)重组蛋白
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度0.5mg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 396 ¥ 924 ¥ 1320 ¥ 3300 ¥ 13200
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对TREM1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别TREM1。
用法
Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPA213Mu01 | 髓细胞触发受体1(TREM1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA213Mu02 | 髓细胞触发受体1(TREM1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA213Mu02 | 髓细胞触发受体1(TREM1)多克隆抗体 | WB; IHC; ICC; IP. |
PAA213Mu01 | 髓细胞触发受体1(TREM1)多克隆抗体 | WB; IHC; ICC; IP. |
SEA213Mu | 髓细胞触发受体1(TREM1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA213Mu | 髓细胞触发受体1(TREM1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages [Aspet: 171462] |
Arthritis Research & Therapy | Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. [pubmed:27624724] |
Chinese medical journal | Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8+ T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis [PMC5443028] |
Journal of Maternal-Fetal & Neonatal Medicine | Increased TLR4 and TREM-1 expression on monocytes and neutrophils in preterm birth: further evidence of a proinflammatory state [Pubmed:29534643] |
Journal of Maternal-Fetal & Neonatal Medicine | A promising novel biomarker for early-onset preeclampsia: soluble trigger receptor expressed on myeloid cells-1 (sTREM-1) [Pubmed: 33207989] |
Ioannis Gkougkourellas, Alexandros Sarantopoulos, Konstantinos Tselios, Athanasios Kalogeridis [] |
留言咨询